Upstate Active Clinical Trials

Study Title:

NCCTG-GLNE 010: Validation and Comparison of Biomarkers for the Early Detection of Colorectal Adenocarcinoma

What is the purpose of the study?

Colon cancer is the second most common cancer in both men and women. It is a disease that can be prevented if it is found early. Colonoscopy is still the best screening tool for colon cancer and the polyps that can lead to colon cancer. However, some people do not like to get or cannot afford to get colonoscopies for a variety of reasons. Researchers are looking for other ways to find colon cancer and the polyps that lead to colon cancer that are as useful and accurate as colonoscopy. We are searching for biomarkers in the blood, urine and stool of a healthy person that could be used to reveal the presence of colorectal cancer before symptoms become apparent.

Upstate Institutional Review Board (IRB) Number:

365232

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Jiri Bem, MD

What is involved if I participate?

  • How long is the study?
    One hour long visit at the Institute of Human Performance
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    blood draw, give urine sample, mail stool samples from home.

Where will the study take place?

Institute for Human Performance

Other Information:

This study offers a $35.00 gift card after all samples for this study have been obtained.

Who can I contact for more information?

Name: Linda J Ellinwood, RN
Phone: 315-464-1852
Email: ellinwol@upstate.edu

Return to Previous Page || Search Again